Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing surgical techniques for pancreatic tumors

Official title: Evaluation of Resection Techniques for Pancreatic Tumors

Run by Methodist Health System · NCT05128890 · Data updated 2026-11-12

This study is testing whether open surgery or minimally invasive surgery works better for people with pancreatic and liver tumors by looking at their recovery and outcomes after the procedures.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment431 (estimated)
SponsorMethodist Health System
Academic / other
Locations1 site (Dallas, Texas)
StatusRecruiting
StartedApril 16, 2016
Main results expectedApril 26, 2027
Study endsApril 26, 2027
Registry record updatedMarch 20, 2026
Trial IDNCT05128890 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 18 and older who have undergone pancreatic or liver resection surgeries at Methodist Dallas Medical Center during the specified time frame.

Probably not a fit

Patients who have not undergone pancreatic or liver resection surgeries or are under 18 years of age will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the outcomes of open versus minimally invasive surgical techniques for pancreatic and liver tumor resections. It involves a retrospective chart review of patients who underwent these surgeries at Methodist Dallas Medical Center from January 2006 to December 2020. The study will analyze various outcome variables, including patient survival, length of hospital stay, complication rates, operative time, transfusion rates, and readmission rates at 30 and 90 days post-surgery.

Why it matters

Potential benefit: If successful, this study could help identify the most effective surgical techniques for improving patient outcomes in pancreatic and liver tumor resections.

How similar studies have gone: Other studies have shown varying success with similar surgical technique comparisons, but this specific evaluation is novel in its comprehensive approach to analyzing multiple outcome variables.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
* Patients 18 years old or older

Exclusion Criteria:

* Patients that have not undergone pancreatic resection surgeries
* Patients under 18 years of age

Where it's running

  • Methodist Dallas Medical Center
    Dallas, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Alejandro Mejia, M.D. — The Liver Institute, Methodist Dallas Medical Center
  • Study coordinator: Colette N Ndjom, MS
  • Email: ClinicalResearch@mhd.com
  • Phone: 214-947-4681

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.